Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · IEX Real-Time Price · USD
1.110
-0.080 (-6.72%)
At close: May 7, 2024, 4:00 PM
1.079
-0.031 (-2.79%)
After-hours: May 7, 2024, 7:59 PM EDT

Seres Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Revenue
126.337.13144.9333.2234.5128.2732.121.7700
Upgrade
Revenue Growth (YoY)
1672.24%-95.08%336.33%-3.74%22.07%-11.94%47.48%---
Upgrade
Gross Profit
126.337.13144.9333.2234.5128.2732.121.7700
Upgrade
Selling, General & Admin
87.7479.6969.2630.7824.7532.634.0432.6216.764.36
Upgrade
Research & Development
145.86172.92141.8990.5780.1495.9689.4681.9938.110.72
Upgrade
Other Operating Expenses
0.71-1.7301.4900000
Upgrade
Operating Expenses
234.31253.62209.42121.35106.38128.55123.5114.6154.8615.08
Upgrade
Operating Income
-107.98-246.49-64.49-88.13-71.88-100.28-91.4-92.84-54.86-15.08
Upgrade
Interest Expense / Income
13.186.022.912.920.500-1.26-0.080.21
Upgrade
Other Expense / Income
-7.44-2.35-1.83-1.93-2.1-1.34-2.02-0.011.42
Upgrade
Pretax Income
-113.72-250.16-65.58-89.13-70.28-98.94-89.38-91.58-54.78-16.71
Upgrade
Net Income
-113.72-250.16-65.58-89.13-70.28-98.94-89.38-91.58-54.78-16.71
Upgrade
Preferred Dividends
0000000001.29
Upgrade
Net Income Common
-113.72-250.16-65.58-89.13-70.28-98.94-89.38-91.58-54.78-18
Upgrade
Shares Outstanding (Basic)
128108928057414040247
Upgrade
Shares Outstanding (Diluted)
128108928057414040247
Upgrade
Shares Change
18.44%17.86%14.93%40.85%39.04%0.73%1.51%69.33%248.73%5.52%
Upgrade
EPS (Basic)
-0.89-2.31-0.72-1.12-1.24-2.43-2.21-2.30-2.33-2.67
Upgrade
EPS (Diluted)
-0.89-2.31-0.72-1.12-1.24-2.43-2.21-2.30-2.33-2.67
Upgrade
Free Cash Flow
-125.33-238.64-2.88-94.2-77.52-64.79-80.222.43-45.21-11.36
Upgrade
Free Cash Flow Per Share
-0.98-2.21-0.03-1.18-1.37-1.59-1.980.56-1.92-1.68
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%--
Upgrade
Operating Margin
-85.48%-3458.05%-44.50%-265.33%-208.31%-354.77%-284.72%-426.53%--
Upgrade
Profit Margin
-90.02%-3509.50%-45.25%-268.33%-203.68%-350.03%-278.44%-420.74%--
Upgrade
Free Cash Flow Margin
-99.21%-3347.88%-1.99%-283.61%-224.67%-229.21%-249.84%103.05%--
Upgrade
EBITDA
-85.43-232.28-53.45-77.31-59.95-91.08-82.12-88.63-54.14-16.31
Upgrade
EBITDA Margin
-67.63%-3258.75%-36.88%-232.76%-173.73%-322.21%-255.83%-407.21%--
Upgrade
Depreciation & Amortization
15.1111.859.228.899.837.867.264.210.730.19
Upgrade
EBIT
-100.55-244.14-62.67-86.2-69.78-98.94-89.38-92.84-54.86-16.5
Upgrade
EBIT Margin
-79.59%-3425.04%-43.24%-259.53%-202.22%-350.03%-278.44%-426.53%--
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).